{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:48:11Z","timestamp":1789854491439,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T00:00:00Z","timestamp":1375488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T00:00:00Z","timestamp":1375488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10753-013-9706-z","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T11:05:22Z","timestamp":1375441522000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Serum Analysis of Coagulation Factors in IPF and NSIP"],"prefix":"10.1007","volume":"37","author":[{"given":"E.","family":"Bargagli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Madioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Refini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,3]]},"reference":[{"key":"9706_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G., H.R. Collard, J.J. Egan, et al. 2011. AN official ATS\/ERS\/JRS\/ALAT statement: IPF evidence-based guidelines for diagnosis and treatment. American Journal of Respiratory and Critical Care Medicine 183: 788\u2013824.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"109","key":"9706_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1183\/09059180.00010905","volume":"17","author":"RC Chambers","year":"2008","unstructured":"Chambers, R.C. 2008. Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling. European Respiratory Review 17(109): 130\u2013137.","journal-title":"European Respiratory Review"},{"key":"9706_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1183\/09031936.00097306","volume":"29","author":"M Wygrecka","year":"2007","unstructured":"Wygrecka, M., P. Markart, C. Ruppert, et al. 2007. Cellular origin of pro-coagulant and antifibrinolytic factors in bleomycin-injured lungs. European Respiratory Journal 29: 1105\u20131114.","journal-title":"European Respiratory Journal"},{"key":"9706_CR4","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1038\/sj.bjp.0707603","volume":"153","author":"RC Chambers","year":"2008","unstructured":"Chambers, R.C. 2008. Procoagulant signalling mechanisms in lung inflammation and fibrosis: new opportunities for pharmacological intervention? British Journal of Pharmacology 153: S367\u2013S378.","journal-title":"British Journal of Pharmacology"},{"key":"9706_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1160\/TH07-11-0666","volume":"99","author":"M Wygrecka","year":"2008","unstructured":"Wygrecka, M., E. Jablonska, A. Guenther, et al. 2008. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thrombosis and Haemostasis 99: 494\u2013501.","journal-title":"Thrombosis and Haemostasis"},{"key":"9706_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00281-011-0281-9","volume":"34","author":"L Ma","year":"2012","unstructured":"Ma, L., and A. Dorling. 2012. The roles of thrombin and protease-activated receptors in inflammation. Seminars in Immunopathology 34: 63\u201372.","journal-title":"Seminars in Immunopathology"},{"key":"9706_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1378\/chest.128.3.1475","volume":"128","author":"H Kubo","year":"2005","unstructured":"Kubo, H., K. Nakayama, M. Yanai, et al. 2005. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128: 1475\u20131482.","journal-title":"Chest"},{"key":"9706_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.humimm.2006.02.026","volume":"67","author":"CM Magro","year":"2006","unstructured":"Magro, C.M., W.J. Waldman, D.A. Knight, et al. 2006. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Human Immunology 67: 284\u2013297.","journal-title":"Human Immunology"},{"key":"9706_CR9","first-page":"2550","volume":"119","author":"CJ Scotton","year":"2009","unstructured":"Scotton, C.J., M.A. Krupiczojc, M. K\u00f6nigshoff, et al. 2009. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. The Journal of Clinical Investigation 119: 2550\u20132563.","journal-title":"The Journal of Clinical Investigation"},{"key":"9706_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1309\/0B06Y93EGE6TQ36Y","volume":"203","author":"CM Magro","year":"2003","unstructured":"Magro, C.M., J. Allen, A. Pope-Harman, et al. 2003. The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. American Journal of Clinical Pathology 203: 556\u2013567.","journal-title":"American Journal of Clinical Pathology"},{"key":"9706_CR11","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1002\/pmic.200600303","volume":"6","author":"B Magi","year":"2006","unstructured":"Magi, B., E. Bargagli, L. Bini, and P. Rottoli. 2006. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 6: 6354\u20136369.","journal-title":"Proteomics"},{"key":"9706_CR12","doi-asserted-by":"publisher","first-page":"L3","DOI":"10.1152\/ajplung.90637.2008","volume":"299","author":"HR Collard","year":"2010","unstructured":"Collard, H.R., C.S. Calfee, P.J. Wolters, et al. 2010. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology 299: L3\u2013L7.","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"9706_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.5858\/2010-0325-RSR.1","volume":"135","author":"NA Sangle","year":"2011","unstructured":"Sangle, N.A., and K.J. Smock. 2011. Antiphospholipid antibody syndrome. Archives of Pathology & Laboratory Medicine 135: 1092\u20131096.","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"9706_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1191\/096120399678840846","volume":"8","author":"D Erkan","year":"1999","unstructured":"Erkan, D., H. Bateman, and M.D. Lockshin. 1999. Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of two cases and review of literature. Lupus 8: 560\u2013564.","journal-title":"Lupus"},{"key":"9706_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1684\/abc.2011.0592","volume":"69","author":"B Visseaux","year":"2011","unstructured":"Visseaux, B., J. Masliah-Planchon, A.M. Fischer, et al. 2011. Antiphospholipid syndrome diagnosis: an update. Annales de Biologie Clinique (Paris) 69: 411\u2013418.","journal-title":"Annales de Biologie Clinique (Paris)"},{"key":"9706_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1164\/rccm.201001-0020OC","volume":"182","author":"R Mehra","year":"2010","unstructured":"Mehra, R., F. Xu, D.C. Babineau, et al. 2010. Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional research of the Cleveland Family Study. American Journal of Respiratory and Critical Care Medicine 182: 826\u2013833.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"9706_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ejso.2005.05.001","volume":"31","author":"S Battistelli","year":"2005","unstructured":"Battistelli, S., A. Vittoria, R. Cappelli, et al. 2005. Protein S in cancer patients with non metastatic solid tumors. European Journal of Surgical Oncology 31: 798\u2013802.","journal-title":"European Journal of Surgical Oncology"},{"key":"9706_CR18","first-page":"225","volume":"76","author":"A Kiziewicz","year":"2008","unstructured":"Kiziewicz, A., E. Zekanowska, K. Cieslinski, et al. 2008. Protein C system in patients with idiopathic pulmonary fibrosis\u2014preliminary report. Pneumonologia i Alergologia Polska 76: 225\u2013228.","journal-title":"Pneumonologia i Alergologia Polska"},{"key":"9706_CR19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G., H.R. Collard, J.J. Egan, et al. 2011. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine 183: 788\u2013824.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"9706_CR20","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1378\/chest.07-0299","volume":"132","author":"R Hyzy","year":"2007","unstructured":"Hyzy, R., S. Huang, J. Myers, et al. 2007. Acute exacerbation of idiopathic pulmonary fibrosis. Chest 132: 1652\u20131658.","journal-title":"Chest"},{"key":"9706_CR21","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino, R., G. Viegi, V. Brusasco, et al. 2005. Interpretative strategies for lung function tests. European Respiratory Journal 26: 948\u2013968.","journal-title":"European Respiratory Journal"},{"key":"9706_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1259\/bjr\/65090500","volume":"84","author":"CR Lloyd","year":"2011","unstructured":"Lloyd, C.R., S.L. Walsh, and D.M. Hansell. 2011. High-resolution CT of complications of idiopathic fibrotic lung disease. British Journal of Radiology 84: 581\u2013592.","journal-title":"British Journal of Radiology"},{"key":"9706_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.rmr.2010.10.035","volume":"28","author":"JM Naccache","year":"2011","unstructured":"Naccache, J.M., and H. Mal. 2011. Management of acute exacerbations of pulmonary fibrosis. Revue des Maladies Respiratoires 28: 517\u2013528.","journal-title":"Revue des Maladies Respiratoires"},{"key":"9706_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.medcli.2009.12.015","volume":"136","author":"JM V\u00e1zquez","year":"2011","unstructured":"V\u00e1zquez, J.M., J.M. Dobano, F.J. Barcala, et al. 2011. Acute exacerbation of idiopathic pulmonary fibrosis. Medicina Clinica 136: 403\u2013407.","journal-title":"Medicina Clinica"},{"key":"9706_CR25","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1097\/01.CCM.0000057846.21303.AB","volume":"31","author":"S Idell","year":"2003","unstructured":"Idell, S. 2003. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. American Journal of Respiratory and Critical Care Medicine 31: S213\u2013S220.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"9706_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.trsl.2011.01.012","volume":"157","author":"KV Pandit","year":"2011","unstructured":"Pandit, K.V., J. Milosevic, and N. Kaminski. 2011. MicroRNAs in idiopathic pulmonary fibrosis. Translational Research 157: 191\u2013199.","journal-title":"Translational Research"},{"key":"9706_CR27","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1164\/ajrccm.157.6.9709078","volume":"157","author":"H Kobayashi","year":"1998","unstructured":"Kobayashi, H., E.C. Gabazza, O. Taguchi, et al. 1998. Protein C anticoagulant system in patients with interstitial lung diseases. American Journal of Respiratory and Critical Care Medicine 157: 1850\u20131854.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"9706_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/107602960000600404","volume":"6","author":"H Yasui","year":"2000","unstructured":"Yasui, H., E.C. Gabazza, O. Taguchi, et al. 2000. Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung disease. Clinical and Applied Thrombosis\/Hemostasis 6: 202\u2013205.","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"9706_CR29","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/art.30255","volume":"63","author":"GS Bogatkevich","year":"2011","unstructured":"Bogatkevich, G.S., A. Ludwicka-Bradley, P.J. Nietert, et al. 2011. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis and Rheumatism 63: 1416\u20131425.","journal-title":"Arthritis and Rheumatism"},{"key":"9706_CR30","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1002\/art.24935","volume":"60","author":"GS Bogatkevich","year":"2009","unstructured":"Bogatkevich, G.S., A. Ludwicka-Bradley, R.M. Silver, et al. 2009. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis and Rheumatism 60: 3455\u20133464.","journal-title":"Arthritis and Rheumatism"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9706-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-013-9706-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9706-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9706-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T10:18:59Z","timestamp":1628072339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-013-9706-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9706"],"URL":"https:\/\/doi.org\/10.1007\/s10753-013-9706-z","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,3]]},"assertion":[{"value":"3 August 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}